stock split
OpGen Announces 1-for-20 Reverse Stock Split
The molecular diagnostics firm recently reported a sharp decline in third quarter revenues amid an increased net loss.
HTG Molecular Diagnostics to Implement Reverse Stock Split
Last month, the company reported a 48 percent year-over-year drop in third quarter revenues as it repositions itself as a developer of drug discovery technologies.
T2 Biosystems Effects Reverse Stock Split, Reports 50 Percent Drop in Preliminary Q3 Revenues
The firm's reverse stock split is intended to bring T2 Bio into compliance with Nasdaq's minimum bid price requirement.
HTG Molecular Completes 1-For-15 Reverse Stock Split
The company stock will now trade on a split-adjusted basis on the Nasdaq after reducing its number of shares from 200 million to 26.7 million.
Biocept Completes Reverse Stock Split, Adds New Managed Care Contract for Liquid Biopsy Tests
The company's stock will now trade on a split-adjusted basis on the Nasdaq after authorization for the split was approved by stockholders.
Aug 28, 2019
OpGen Plans Reverse Stock Split
Apr 26, 2019
Precipio to Effect 1-for-15 Reverse Stock Split
Jan 17, 2018
OpGen to Execute 1-for-25 Reverse Stock Split
Jun 2, 2017
Pressure Biosciences Plans Reverse Stock Split
Mar 16, 2017
Rosetta Genomics Announces Reverse Stock Split
Dec 28, 2016
Interpace Effecting a 1-for-10 Reverse Stock Split
Dec 23, 2016
Great Basin to Effect 1-for-300 Reverse Stock Split
Nov 28, 2016
WaferGen Enacts Reverse Stock Split
Oct 11, 2016
Roka Bioscience Plans 1-for-10 Reverse Stock Split
Sep 15, 2016
Great Basin Scientific Plans Reverse Stock Split
Jan 27, 2016
CombiMatrix Initiates 1-for-15 Reverse Stock Split
Oct 8, 2015